PHILADELPHIA -- DuPont Co. has agreed to sell its Compound Semiconductor Solutions business to SK Siltron, a Korean silicon wafer maker that has been building itself up as a rival to computer suppliers from the U.S., Japan and China, for $450 million, the buyer said Tuesday.
DuPont shares rose 1.5% in morning trading to $71.62, its highest price since early last month but still below where it traded when Edward Breen, now executive chairman, became CEO in 2015.
The semiconductor business is "state of the art," but "is not a strategic priority" for DuPont's Electronics & Imaging group, its president, Jon Kemp, said in a statement. "SK Siltron will be a better owner." The group employs around 55 in the U.S., mostly at a site in Auburn, Mich., and plants in East Asia.
The sale came a week after DuPont said it has spun off its 700-employee DuPont Sustainable Solutions (DSS) unit in a management-led private-equity buyout "as an independent global operations management consulting firm" for client corporations, under chief executive Davide Vassallo and backed by Switzerland-based Gyrus Capital.
DuPont in a statement said that decision "responds to a growing client need to rapidly access solutions for evolving global challenges, including advancing technologies, maturing systems and processes, the changing workforce, the digital revolution and plateaued safety performance." DuPont CEO Marc Doyle called Vassallo's staff "well-positioned" for "this exciting endeavor." Though it is separate, DSS will use DuPont offices and its oval logo, for a time.
The new business' board includes Vassallo, CFO Vladimir Kral, DuPont Safety & Construction boss Rose Lee, and three representatives of Gyrus, a firm formed last year by European and U.S. buyout investors. Terms of the spinoff weren't immediately disclosed.
Based in Wilmington, DuPont is in the process of selling businesses with $2 billion in yearly sales, under executive chairman Edward Breen. He previously dismembered another locally-based conglomerate, the former Tyco International, in the 2000s, cutting costs while boosting the value of investors and executives' shareholdings as buyers paid premium prices for business units.
DuPont separated from Dow Chemical in April and from Wilmington-based Corteva, the pesticide and genetically-modified seed company, in June, leaving it with a group of businesses supplying automotive, aerospace, construction, electronics, food-processing, medical and military-and-security buyers, with sales totaling around $22 billion a year, before the recent divestitures.
A Bloomberg LP report characterized the businesses DuPont is selling as units with "volatile" sales or profits, led by "environmentally-oriented products including solar-panel materials and corn-derived Sorona textiles, as well as consulting services that help companies cut pollution and reduce energy use."
Several such initiatives were associated with former DuPont CEO Ellen Kullman, who was ousted four years ago in a shareholder rebellion led by hedge fund investor Nelson Peltz. The effort was backed by institutional investors frustrated by decades of expensive deals that enriched some DuPont bosses but didn't boost its share price, or create enough high-profit products to secure a fat return on research and development spending.
Peltz and his supporters succeeded in forcing a restructuring of the company, the merger with Dow and hiring of Breen, more share repurchases to prop up the share price, lower and more-targeted research spending, and other cutbacks. But all that failed to boost its share price despite their bold predictions. Discouraged, Peltz's Trian Partners sold its DuPont stake two years ago.
In the company's July conference call, Breen said he was hopeful about prospects for selling more DuPont "non-core" businesses.
Questioned by analysts, Doyle, the DuPont CEO, said the company's business sale prospects were not dimmed by fears of a slowing economy. "The assets that we are putting up for sale are good product lines," he added. "We're feeling pretty good about the cash generation potential."
(c)2019 The Philadelphia Inquirer
Visit The Philadelphia Inquirer at www.inquirer.com
Distributed by Tribune Content Agency, LLC.